Conversely, lingering downregulation of StarD5 with prolonged lipid-cholesterol excess accelerates fatty liver’s transition to fibrosis; mediated via dysregulation in the oxysterol signaling pathway. This evidence concerns the gene STARD5 and fatty liver disease.